Navigation Links
Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19
Date:6/11/2020

Cryo-Cell International’s announcement comes on the heel of increased demand for masks and other protective measures to protect workers in the medical field. The face masks will be distributed nationwide to obstetrical and gynecological doctors and their dedicated staffs who valiantly risk their lives every day to provide healthcare to pregnant women. The delivery of masks is scheduled to begin later this week.

In addition to face mask donations, Cryo-Cell International has and will contribute other essential supplies within the medical field including face shields, hand sanitizers, and informational pieces regarding COVID-19 for practitioners and pregnant patients alike.

David Portnoy, Cryo-Cell International’s Chairman and Co-CEO, stated, “We recognize and salute the vital role that physicians and other healthcare providers play in taking care of pregnant women, especially during the COVID-19 pandemic. In support of their noble efforts, Cryo-Cell International is proud to provide essential medical items to allow them to provide the highest quality care for their patients.”

Cryo-Cell International remains committed to providing clients with premier cord blood and cord tissue preservation service and aiding in the advancement of regenerative medicine. As research continues to develop in finding treatments for COVID-19 through the use of mesenchymal stem cells found in cord tissue, the company continues to help expecting parents protect what matters most through umbilical stem cell preservation. Cryo-Cell International anticipates ongoing plans to aid in financial contributions and personal protective equipment donations to help safeguard the efforts of essential workers in OBGYN practices around the United States during COVID-19.

About Cryo-Cell International, Inc.

Founded in 1989, Cryo-Cell International, Inc. is the world's first private cord blood bank. More than 500,000 parents from 87 countries trust Cryo-Cell to preserve their family members' stem cells. Cryo-Cell's mission is to provide clients with state-of-the-art stem cell cryopreservation services and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is FDA registered, cGMP-/cGTP-compliant, and is licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell is also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. In addition, Cryo-Cell is ISO 9001:2008 certified by BSI, an internationally recognized, quality assessment organization. Cryo-Cell is a publicly-traded company, OTCQB:CCEL. For more information, please visit http://www.cryo-cell.com. For a complete list of references, visit http://www.cryo-cell.com/references.

Forward-Looking Statement
Statements wherein the terms "believes", "intends", "projects", "anticipates", "expects", and similar expressions as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company, which include future medical and research developments. The Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements.

Read the full story at https://www.prweb.com/releases/cryo_cell_to_donate_50_000_face_masks_to_obgyn_practices_and_patients_around_the_country_amidst_covid_19/prweb17151367.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Cryo-Cell Confirms Specimen Longevity of 23+ Years with Optimal CD34 Viability
2. Cryo-Cell International Expands Its Board Of Directors
3. In Honor of Military Appreciation Month, Enso Discoveries Donates $1,000 to the Green Beret Foundation to Help Families of the Wounded, and Those Suffering from Loss
4. SuperCom Subsidiary LCA Awarded a New $750,000 to $2.5 Million Program by California County
5. EUR 750,000 in funding for new Competence Center for HPC in the Natural Sciences at Mainz
6. San Antonio Life Sciences Institute awards $750,000 to innovators
7. UTSA and SwRI award $250,000 to advance clean emissions, explore antimicrobials
8. Study of Brazilian Amazon shows 50,000 km of road was built in just 3 years
9. Soft-Tex Announces Donation of 10,000 Masks to Local New York Organizations to Protect Against Coronavirus
10. LabRoots’ Genetics Virtual Week Announces Three-Day Agenda for 2020 Event, Dedicated to Advancing Best Practices in Genomics, Molecular Diagnostics and Precision Medicine
11. EU MDR: Best Practices for UDI Data & Product Labeling, Upcoming Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... development services, today announced that the company has received ISO9001:2015 certification for ... diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , ... sciences and food industries, is pleased to announce that Charles Galea has joined ... Development. , Charles is an accomplished and results-driven sales executive with over 10 ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology: